Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 3 |
2021 | 1 |
2022 | 2 |
2023 | 2 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Pembrolizumab for the treatment of colorectal cancer.
Expert Opin Biol Ther. 2020 Mar;20(3):219-226. doi: 10.1080/14712598.2020.1718095. Epub 2020 Feb 3.
Expert Opin Biol Ther. 2020.
PMID: 31952453
Review.
EGFR mutation-positive NSCLC: factors to consider when deciding first-line therapy.
Hulo P, Coupez D, Denis MG, Bennouna J.
Hulo P, et al. Among authors: coupez d.
Expert Rev Anticancer Ther. 2020 May;20(5):365-372. doi: 10.1080/14737140.2020.1757439. Epub 2020 Apr 26.
Expert Rev Anticancer Ther. 2020.
PMID: 32302244
Review.
Item in Clipboard
KRAS mutations in metastatic colorectal cancer: from a de facto ban on anti-EGFR treatment in the past to a potential biomarker for precision medicine.
Coupez D, Hulo P, Touchefeu Y, Denis MG, Bennouna J.
Coupez D, et al.
Expert Opin Biol Ther. 2021 Oct;21(10):1325-1334. doi: 10.1080/14712598.2021.1967318. Epub 2021 Aug 18.
Expert Opin Biol Ther. 2021.
PMID: 34378483
Review.
Item in Clipboard
Overview of premedication prescription and intake in an oncology day hospital: What do we need to change to improve patient management?
Goubil A, Lallier L, Peyrilles E, Coupez D, Gouill CL, Fronteau C, Cormier N.
Goubil A, et al. Among authors: coupez d.
J Oncol Pharm Pract. 2024 Jan;30(1):88-99. doi: 10.1177/10781552231168314. Epub 2023 Apr 10.
J Oncol Pharm Pract. 2024.
PMID: 37038369
Review.
Item in Clipboard
Immune Checkpoint Inhibitors Rechallenge Efficacy in Non-Small-Cell Lung Cancer Patients.
Gobbini E, Toffart AC, Pérol M, Assié JB, Duruisseaux M, Coupez D, Dubos C, Westeel V, Delaunay M, Guisier F, Veillon R, Gounant V, Giroux Leprieur E, Vanel FR, Chaabane N, Dansin E, Babey H, Decroisette C, Barlesi F, Daniel C, Fournel P, Mezquita L, Oulkhouir Y, Canellas A, Duchemann B, Molinier O, Alcazer V, Moro-Sibilot D, Levra MG.
Gobbini E, et al. Among authors: coupez d.
Clin Lung Cancer. 2020 Sep;21(5):e497-e510. doi: 10.1016/j.cllc.2020.04.013. Epub 2020 May 8.
Clin Lung Cancer. 2020.
PMID: 32605892
Item in Clipboard
MiR-31-3p do not predict anti-EGFR efficacy in first-line therapy of RAS wild-type metastatic right-sided colon cancer.
Boisteau E, Lespagnol A, De Tayrac M, Corre S, Perrot A, Rioux-Leclercq N, Martin-Lannerée S, Artru P, Chalabreysse P, Poureau PG, Doucet L, Coupez D, Bennouna J, Bossard C, Coriat R, Beuvon F, Bauguion L, Leclair F, Chautard R, Lecomte T, Guyetant S, Desgrippes R, Grasset D, Lhostis H, Bouhier-Leporrier K, Bibeau F, Edeline J, Galibert MD, Lièvre A.
Boisteau E, et al. Among authors: coupez d.
Clin Res Hepatol Gastroenterol. 2022 May;46(5):101888. doi: 10.1016/j.clinre.2022.101888. Epub 2022 Feb 18.
Clin Res Hepatol Gastroenterol. 2022.
PMID: 35189426
Free article.
Item in Clipboard
Response to first line platinum-based chemotherapy in mismatch repair deficient (MMRd)/ microsatellite instability high (MSI-high) endometrial carcinoma.
Colomba E, Alexandre J, Le Teuff G, Genestie C, Coupez D, Coquard IR, Brachet PE, de Percin S, Sajous C, Fabbro M, Delanoy N, Joly F, Frenel JS, Pautier P, Leary A.
Colomba E, et al. Among authors: coupez d.
Gynecol Oncol. 2023 Feb;169:78-84. doi: 10.1016/j.ygyno.2022.11.029. Epub 2022 Dec 13.
Gynecol Oncol. 2023.
PMID: 36521352
Item in Clipboard
Cite
Cite